H S Kanyerere1, J Mpunga1, H Tweya2, M Edginton3, A D Harries4, S G Hinderaker5, F Chimbwandira6, A Gonani7, K Mbendera1. 1. National Tuberculosis Programme, Ministry of Health, Lilongwe, Malawi. 2. Lighthouse Trust, Lilongwe, Malawi. 3. Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, Paris, France. 4. Centre for Operational Research, International Union Against Tuberculosis and Lung Disease, Paris, France ; London School of Hygiene & Tropical Medicine, London, United Kingdom. 5. Centre for International Health, University of Bergen, Bergen, Norway. 6. HIV and AIDS Department, Ministry of Health, Lilongwe, Malawi. 7. Queen Elizabeth Central Hospital, Blantyre, Malawi.
Abstract
SETTING: Queen Elizabeth Central Hospital, Blantyre, Malawi. OBJECTIVES: To determine 1) the proportion of human immunodeficiency virus (HIV) infected tuberculosis (TB) patients started on antiretroviral therapy (ART), 2) the timing of ART and 3) the effect of the timing on TB treatment outcomes. DESIGN: A retrospective record review of HIV-infected TB patients registered from January to December 2009. RESULTS: A total of 3376 TB patients were registered, of whom 2665 (79%) were HIV-tested and 2042 (77%) were HIV-infected. A total of 1190 HIV-infected TB patients who were not on ART at the time of starting TB treatment were studied. Of 688 (58%) who started ART, 61% started therapy within 2 months of anti-tuberculosis treatment and 39% started later (≥2 months). Treatment success for patients with TB who started ART within 2 months was higher than for those starting ART later (RR 1.6, 95%CI 1.4-1.8), and death rates were lower (RR 0.25, 95%CI 0.19-0.35). CONCLUSION: Under routine programme conditions in Malawi, a higher proportion of HIV-infected TB patients who started ART did so within 2 months of starting TB treatment, and early ART intervention was associated with better treatment outcomes. This confirms recommendations that co-infected TB patients should start ART early.
SETTING: Queen Elizabeth Central Hospital, Blantyre, Malawi. OBJECTIVES: To determine 1) the proportion of human immunodeficiency virus (HIV) infected tuberculosis (TB) patients started on antiretroviral therapy (ART), 2) the timing of ART and 3) the effect of the timing on TB treatment outcomes. DESIGN: A retrospective record review of HIV-infected TBpatients registered from January to December 2009. RESULTS: A total of 3376 TB patients were registered, of whom 2665 (79%) were HIV-tested and 2042 (77%) were HIV-infected. A total of 1190 HIV-infected TBpatients who were not on ART at the time of starting TB treatment were studied. Of 688 (58%) who started ART, 61% started therapy within 2 months of anti-tuberculosis treatment and 39% started later (≥2 months). Treatment success for patients with TB who started ART within 2 months was higher than for those starting ART later (RR 1.6, 95%CI 1.4-1.8), and death rates were lower (RR 0.25, 95%CI 0.19-0.35). CONCLUSION: Under routine programme conditions in Malawi, a higher proportion of HIV-infected TBpatients who started ART did so within 2 months of starting TB treatment, and early ART intervention was associated with better treatment outcomes. This confirms recommendations that co-infected TB patients should start ART early.
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Lancet Date: 2007-10-20 Impact factor: 79.321
Authors: Diane V Havlir; Michelle A Kendall; Prudence Ive; Johnstone Kumwenda; Susan Swindells; Sarojini S Qasba; Anne F Luetkemeyer; Evelyn Hogg; James F Rooney; Xingye Wu; Mina C Hosseinipour; Umesh Lalloo; Valdilea G Veloso; Fatuma F Some; N Kumarasamy; Nesri Padayatchi; Breno R Santos; Stewart Reid; James Hakim; Lerato Mohapi; Peter Mugyenyi; Jorge Sanchez; Javier R Lama; Jean W Pape; Alejandro Sanchez; Aida Asmelash; Evans Moko; Fred Sawe; Janet Andersen; Ian Sanne Journal: N Engl J Med Date: 2011-10-20 Impact factor: 91.245
Authors: A D Harries; D S Nyangulu; C Kang'ombe; D Ndalama; J R Glynn; H Banda; J J Wirima; F M Salaniponi; G Liomba; D Maher; P Nunn Journal: Trans R Soc Trop Med Hyg Date: 1998 May-Jun Impact factor: 2.184
Authors: K Tayler-Smith; R Zachariah; M Manzi; W Kizito; A Vandenbulcke; J Sitienei; J Chakaya; A D Harries Journal: Trop Med Int Health Date: 2011-08-11 Impact factor: 2.622
Authors: William Worodria; Victor Ssempijja; Coleen Hanrahan; Richard Ssegonja; Abdallah Muhofwa; Doreen Mazapkwe; Harriet Mayanja-Kizza; Steven J Reynolds; Robert Colebunders; Yukari C Manabe Journal: AIDS Date: 2018-09-24 Impact factor: 4.177